Stock comparison
Kadant
KAI$3.6BIndustrials Market cap, Sector
Mycronic AB (publ)
MYCR.ST$59.56BIndustrials Market cap, Sector
Overall winner
Mycronic AB (publ)
KAI 07 MYCR.ST
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
KAI0wins
7winsMYCR.ST
56D
B77
82B
A85
44F
A85
53D
C69
41F
C66
46D
B78
45D
B77
Side-by-side metrics
| Metric | KAI | MYCR.ST |
|---|---|---|
| Market cap | $3.6B | $59.56B Winner |
| P/E (TTM) | Winner: 36.2x | 37.5x |
| EV/EBIT | Winner: 25.4x | 29.1x |
| ROIC (TTM) | 7.51% | 20.79% Winner |
| Gross margin | 44.96% | 52.44% Winner |
| Net margin | 9.45% | 19.65% Winner |
| Revenue CAGR 5y | 7.55% | 15.75% Winner |
| EPS CAGR 5y | 4.51% | 28.15% Winner |
| Debt / Equity | 0.4x | 0.0x Winner |
| Dividend yield | 0.43% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
KAI leads on
- EV/EBIT25.4xvs 29.1x+13%
MYCR.ST leads on
- Market cap$59.56Bvs $3.6B+94%
- Debt / Equity0.0xvs 0.4x+88%
- EPS CAGR 5y28.15%vs 4.51%+84%
- ROIC (TTM)20.79%vs 7.51%+64%
More like KAI
More like MYCR.ST
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.